432 related articles for article (PubMed ID: 28596261)
1. Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ; Jonasch E; Agarwal N; Bhayani S; Bro WP; Chang SS; Choueiri TK; Costello BA; Derweesh IH; Fishman M; Gallagher TH; Gore JL; Hancock SL; Harrison MR; Kim W; Kyriakopoulos C; LaGrange C; Lam ET; Lau C; Michaelson MD; Olencki T; Pierorazio PM; Plimack ER; Redman BG; Shuch B; Somer B; Sonpavde G; Sosman J; Dwyer M; Kumar R
J Natl Compr Canc Netw; 2017 Jun; 15(6):804-834. PubMed ID: 28596261
[TBL] [Abstract][Full Text] [Related]
2. NCCN Guidelines Updates: Management of Metastatic Kidney Cancer.
Jonasch E
J Natl Compr Canc Netw; 2019 May; 17(5.5):587-589. PubMed ID: 31117033
[TBL] [Abstract][Full Text] [Related]
3. NCCN clinical practice guidelines in oncology: kidney cancer.
Motzer RJ; Agarwal N; Beard C; Bolger GB; Boston B; Carducci MA; Choueiri TK; Figlin RA; Fishman M; Hancock SL; Hudes GR; Jonasch E; Kessinger A; Kuzel TM; Lange PH; Levine EG; Margolin KA; Michaelson MD; Olencki T; Pili R; Redman BG; Robertson CN; Schwartz LH; Sheinfeld J; Wang J
J Natl Compr Canc Netw; 2009 Jun; 7(6):618-30. PubMed ID: 19555584
[No Abstract] [Full Text] [Related]
4. NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Bagshaw H; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Gunn A; Haas N; Johnson M; Kapur P; King J; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Sweis R; Zibelman M; Schonfeld R; Stein M; Gurski LA
J Natl Compr Canc Netw; 2024 Feb; 22(1):4-16. PubMed ID: 38394781
[TBL] [Abstract][Full Text] [Related]
5. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
Motzer RJ; Jonasch E; Agarwal N; Alva A; Baine M; Beckermann K; Carlo MI; Choueiri TK; Costello BA; Derweesh IH; Desai A; Ged Y; George S; Gore JL; Haas N; Hancock SL; Kapur P; Kyriakopoulos C; Lam ET; Lara PN; Lau C; Lewis B; Madoff DC; Manley B; Michaelson MD; Mortazavi A; Nandagopal L; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Sosman J; Dwyer MA; Gurski LA; Motter A
J Natl Compr Canc Netw; 2022 Jan; 20(1):71-90. PubMed ID: 34991070
[TBL] [Abstract][Full Text] [Related]
6. NCCN Guidelines Insights: Kidney Cancer, Version 2.2020.
Motzer RJ; Jonasch E; Michaelson MD; Nandagopal L; Gore JL; George S; Alva A; Haas N; Harrison MR; Plimack ER; Sosman J; Agarwal N; Bhayani S; Choueiri TK; Costello BA; Derweesh IH; Gallagher TH; Hancock SL; Kyriakopoulos C; LaGrange C; Lam ET; Lau C; Lewis B; Manley B; McCreery B; McDonald A; Mortazavi A; Pierorazio PM; Ponsky L; Redman BG; Somer B; Wile G; Dwyer MA; ; Hammond LJ; Zuccarino-Catania G
J Natl Compr Canc Netw; 2019 Nov; 17(11):1278-1285. PubMed ID: 31693980
[TBL] [Abstract][Full Text] [Related]
7. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA;
J Natl Compr Canc Netw; 2013 May; 11(5):519-28. PubMed ID: 23667203
[TBL] [Abstract][Full Text] [Related]
8. NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.
Motzer RJ; Jonasch E; Boyle S; Carlo MI; Manley B; Agarwal N; Alva A; Beckermann K; Choueiri TK; Costello BA; Derweesh IH; Desai A; George S; Gore JL; Haas N; Hancock SL; Kyriakopoulos C; Lam ET; Lau C; Lewis B; Madoff DC; McCreery B; Michaelson MD; Mortazavi A; Nandagopal L; Pierorazio PM; Plimack ER; Ponsky L; Ramalingam S; Shuch B; Smith ZL; Somer B; Sosman J; Dwyer MA; Motter AD
J Natl Compr Canc Netw; 2020 Sep; 18(9):1160-1170. PubMed ID: 32886895
[TBL] [Abstract][Full Text] [Related]
9. Management of kidney cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2012.
Chiong E; Tay MH; Tan MH; Kumar S; Sim HG; Teh BT; Umbas R; Chau NM
Lancet Oncol; 2012 Nov; 13(11):e482-91. PubMed ID: 23117003
[TBL] [Abstract][Full Text] [Related]
10. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
Thompson JA; Schneider BJ; Brahmer J; Achufusi A; Armand P; Berkenstock MK; Bhatia S; Budde LE; Chokshi S; Davies M; Elshoury A; Gesthalter Y; Hegde A; Jain M; Kaffenberger BH; Lechner MG; Li T; Marr A; McGettigan S; McPherson J; Medina T; Mohindra NA; Olszanski AJ; Oluwole O; Patel SP; Patil P; Reddy S; Ryder M; Santomasso B; Shofer S; Sosman JA; Wang Y; Zaha VG; Lyons M; Dwyer M; Hang L
J Natl Compr Canc Netw; 2022 Apr; 20(4):387-405. PubMed ID: 35390769
[TBL] [Abstract][Full Text] [Related]
11. Management of Immunotherapy-Related Toxicities, Version 1.2019.
Thompson JA; Schneider BJ; Brahmer J; Andrews S; Armand P; Bhatia S; Budde LE; Costa L; Davies M; Dunnington D; Ernstoff MS; Frigault M; Hoffner B; Hoimes CJ; Lacouture M; Locke F; Lunning M; Mohindra NA; Naidoo J; Olszanski AJ; Oluwole O; Patel SP; Reddy S; Ryder M; Santomasso B; Shofer S; Sosman JA; Wahidi M; Wang Y; Johnson-Chilla A; Scavone JL
J Natl Compr Canc Netw; 2019 Mar; 17(3):255-289. PubMed ID: 30865922
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of advanced renal cell carcinoma.
Khanna A; Crane A; Yerram N; Sun D; Ericson K; Lundy SD; Abouassaly R
Clin Adv Hematol Oncol; 2018 Jun; 16(6):438-446. PubMed ID: 30067615
[TBL] [Abstract][Full Text] [Related]
13. Consensus paper: current state of first- and second-line therapy in advanced clear-cell renal cell carcinoma.
Goebell PJ; Ivanyi P; Bedke J; Bergmann L; Berthold D; Boegemann M; Busch J; Doehn C; Krege S; Retz M; Amsberg GV; Grimm MO; Gruenwald V
Future Oncol; 2020 Oct; 16(29):2307-2328. PubMed ID: 32964728
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Hoppe RT; Advani RH; Ai WZ; Ambinder RF; Armand P; Bello CM; Benitez CM; Bierman PJ; Boughan KM; Dabaja B; Gordon LI; Hernandez-Ilizaliturri FJ; Herrera AF; Hochberg EP; Huang J; Johnston PB; Kaminski MS; Kenkre VP; Khan N; Lynch RC; Maddocks K; McConathy J; McKinney M; Metzger M; Morgan D; Mulroney C; Rabinovitch R; Rosenspire KC; Seropian S; Tao R; Winter JN; Yahalom J; Burns JL; Ogba N
J Natl Compr Canc Netw; 2020 Jun; 18(6):755-781. PubMed ID: 32502987
[TBL] [Abstract][Full Text] [Related]
15. Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
Benson AB; Venook AP; Cederquist L; Chan E; Chen YJ; Cooper HS; Deming D; Engstrom PF; Enzinger PC; Fichera A; Grem JL; Grothey A; Hochster HS; Hoffe S; Hunt S; Kamel A; Kirilcuk N; Krishnamurthi S; Messersmith WA; Mulcahy MF; Murphy JD; Nurkin S; Saltz L; Sharma S; Shibata D; Skibber JM; Sofocleous CT; Stoffel EM; Stotsky-Himelfarb E; Willett CG; Wu CS; Gregory KM; Freedman-Cass D
J Natl Compr Canc Netw; 2017 Mar; 15(3):370-398. PubMed ID: 28275037
[TBL] [Abstract][Full Text] [Related]
16. NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.
Gradishar WJ; Moran MS; Abraham J; Aft R; Agnese D; Allison KH; Blair SL; Burstein HJ; Dang C; Elias AD; Giordano SH; Goetz MP; Goldstein LJ; Hurvitz SA; Isakoff SJ; Jankowitz RC; Javid SH; Krishnamurthy J; Leitch M; Lyons J; Matro J; Mayer IA; Mortimer J; O'Regan RM; Patel SA; Pierce LJ; Rugo HS; Sitapati A; Smith KL; Smith ML; Soliman H; Stringer-Reasor EM; Telli ML; Ward JH; Wisinski KB; Young JS; Burns JL; Kumar R
J Natl Compr Canc Netw; 2021 May; 19(5):484-493. PubMed ID: 34794122
[TBL] [Abstract][Full Text] [Related]
17. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines.
Benson AB; Bekaii-Saab T; Chan E; Chen YJ; Choti MA; Cooper HS; Engstrom PF; Enzinger PC; Fakih MG; Fenton MJ; Fuchs CS; Grem JL; Hunt S; Kamel A; Leong LA; Lin E; May KS; Mulcahy MF; Murphy K; Rohren E; Ryan DP; Saltz L; Sharma S; Shibata D; Skibber JM; Small W; Sofocleous CT; Venook AP; Willett CG; Gregory KM; Freedman-Cass DA
J Natl Compr Canc Netw; 2013 Feb; 11(2):141-52; quiz 152. PubMed ID: 23411381
[TBL] [Abstract][Full Text] [Related]
18. Personalized Management of Advanced Kidney Cancer.
Graham J; Heng DYC; Brugarolas J; Vaishampayan U
Am Soc Clin Oncol Educ Book; 2018 May; 38():330-341. PubMed ID: 30231375
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors and molecular markers for renal cell carcinoma.
Bui MH; Zisman A; Pantuck AJ; Han KR; Wieder J; Belldegrun AS
Expert Rev Anticancer Ther; 2001 Dec; 1(4):565-75. PubMed ID: 12113089
[TBL] [Abstract][Full Text] [Related]
20. Kidney cancer, version 2.2014.
Motzer RJ; Jonasch E; Agarwal N; Beard C; Bhayani S; Bolger GB; Chang SS; Choueiri TK; Derweesh IH; Gupta S; Hancock SL; Kim JJ; Kuzel TM; Lam ET; Lau C; Levine EG; Lin DW; Margolin KA; Michaelson MD; Olencki T; Pili R; Plimack ER; Rampersaud EN; Redman BG; Ryan CJ; Sheinfeld J; Sircar K; Somer B; Wang J; Wilder RB; Dwyer MA; Kumar R;
J Natl Compr Canc Netw; 2014 Feb; 12(2):175-82. PubMed ID: 24586079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
